Panacea Biotec Receives Tribunal Awards Related to Workmen Dispute

Panacea Biotec Receives Tribunal Awards Related to Workmen Dispute

Panacea Biotec Receives Tribunal Awards Related to Workmen Dispute​

Panacea Biotec Limited has been involved in a legal matter with the Industrial Tribunal, S.A.S. Nagar, Mohali, regarding several workman disputes. The company received four awards from the Presiding Officer (in the rank of Additional District Judge) of the Industrial Tribunal concerning these matters, which pertain to the period starting from 2014 onwards.

The awarded contents relate significantly to workforce status and compensation. Among the key decisions made by the Tribunal were the setting aside of the transfer of 23 workmen, granting full back wages corresponding to the date of transfer, and awarding reasonable wage revision for these workmen. Additionally, the awards included the reinstatement of workers who had not settled their disputes, mandating 50% back wages from the termination date.

The key details regarding the communication received and the company's action are summarized below:

ParticularsDetails
Authority providing AwardsPresiding Officer (in the rank of Additional District Judge) of Industrial Tribunal, S.A.S. Nagar, Mohali
Date of Award ReceiptApril 9, 2026
Impact on WorkersSet aside transfer for 23 workmen; granted reasonable wage revision; awarded reinstatement with 50% back wages for non-settled disputes.
Financial Implications (Company View)The Company maintains that the awards are challengeable and does not foresee any material adverse impact arising from them on its financial or operational activities.

In response to the tribunal decisions, Panacea Biotec Limited initiated legal action concerning the four awards. The company has filed appeals before the Hon'ble High Court of Punjab and Haryana, Chandigarh, specifically contesting three of the Awards. Furthermore, the company is in the process of filing an appeal against the remaining fourth Award.

PANACEABIO Stock Price Movement​

On Tuesday, Panacea Biotec Limited shares edged higher, gaining 0.26% to settle at ₹538.40 after reporting modest gains in the session. The equity movement was marked by a trade volume of 178,464 shares during the period reviewed.
 

Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.

The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.

Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.

Last edited by a moderator:
Back
Top